Captrust Financial Advisors »

Akebia Therapeutics shares owned by Captrust Financial Advisors

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Captrust Financial Advisors from 13F filings

Historical chart of Captrust Financial Advisors investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Captrust Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Captrust Financial Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $27k 10k 2.73
2025-03-31 $63k 33k 1.92
2024-12-31 $24k 13k 1.90
2022-06-30 $0 10 0.00
2022-03-31 $0 10 0.00
2021-12-31 $0 10 0.00
2021-09-30 $0 10 0.00
2021-06-30 $1.0k 367 2.72
2021-03-31 $2.0k 462 4.33

More positions owned by Captrust Financial Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Apple Stock (AAPL)
Ishares 1-3 Year Treasury Bond Etf Etf (SHY)
Microsoft Corp Stock (MSFT)
Vanguard Value Etf (VTV)
Nvidia Corporation Stock (NVDA)
Vanguard S&p 500 Etf Etf (VOO)
Vanguard Growth Etf Etf (VUG)
Ishares Core Msci Total International Stock Etf Etf (IXUS)
Ishares 3-7 Year Treasury Bond Etf Etf (IEI)
Vanguard Mega Cap Growth Etf Etf (MGK)
Vanguard Small-cap Etf Etf (VB)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Ishares Core Msci Emerging Market Etf Etf (IEMG)

View all positions for Captrust Financial Advisors

Top funds holding Akebia Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Morgan Stanley
Renaissance Technologies
UBS Group
Citadel Advisors
Qube Research & Technologies
MPM Oncology Impact Management
Millennium Management
Franklin Resources
Northern Trust
Affinity Asset Advisors
Invesco

View all funds holding Akebia Therapeutics